ConductScience.org, home

Gene · 2829

NIH grants1,173

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleXCR1 papersNewest fiscal year
P30ES017885Michigan Center on Lifestage Environmental Exposures and Disease (M-LEEaD)22025
R01AI121209Cooperation between lymphatic stroma and hematopoietic cells shapes protective immunity22025
R01AI162643Molecular Basis of cDC1 Development22025
R01AI163223A mechanism to minimize auto-reactivity in the tissue-resident memory T cell pool22025
R01AI168423Evolution and design of metamorphic fold-switching proteins22025
R01CA187975Regulation of stem-like CD8+ T cells and their role in immunotherapy22025
R01CA197363The Tumor Microenvironment Niche of Type I conventional Dendritic Cells22025
R01CA218668Computational and experimental methods for scalable identification of oncogenic non-coding regions22025
R01CA248919Understanding the Mechanisms of DC Licensing in CD8 T Cell Priming22025
R01DE026728Restoring the Immunogenicity of Head and Neck Cancer22025
R01LM012806Predicting Phenotype by Deep Learning Heterogeneous Multi-Omics Data22025
R24AI108564Research Resources: Epigenomic and Transcriptomic Profile of Human Immune Cells22025
R35HL145241Vascular macrophages and T cells in atherosclerosis22025
R37CA246239Potentiating Checkpoint Blockade by Cross-Priming Tumor-Reactive T cells with In Situ Vaccination22025
T15LM011271San Diego Biomedical Informatics Education & Research (SABER)22025
T32AI007290Molecular and Cellular Immunobiology22025
T32AI007313Immunology Training Program22025
T32AI007413Research Training in Experimental Immunology22025
T32AI007496Interdisciplinary Training Program in Immunology22025
T32CA009109Cancer Research Training Program: From Molecular Mechanisms to Therapeutic Strategies22025

Source NIH's project filesgene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/2829/grants?page=3